Advertisement

Topics

Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection

20:00 EDT 5 Jul 2018 | AAAS

(Beth Israel Deaconess Medical Center) A team of researchers led by Beth Israel Deaconess Medical Center's Dan H. Barouch, M.D., Ph.D., in collaboration with Janssen Vaccines & Prevention and others, evaluated a series of preventative HIV vaccine regimens in uninfected human volunteers. In a similarly designed study, Barouch and colleagues tested the same vaccine for its ability to protect rhesus monkeys challenged with an HIV-like virus from infection. The findings showed the vaccines induced robust and comparable immune responses in humans and monkeys and protected monkeys against infection.

Original Article: Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection

NEXT ARTICLE

More From BioPortfolio on "Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...